You searched for "outcomes"

1626 results found

Key research and practical information to inform INS care

This ‘tutorial’ format paper aims to translate key research findings and conclusions into practical terms, discuss their clinical utility and introduce a new clinical method that accurately measures the static visual deficits in infantile nystagmus (INS), predicts the improvements that...

What’s new in glaucoma? Clinical trials drive practice changes, surgical advancements gather pace

Rod McNeil reviews the latest developments in the treatment of glaucoma in the UK. Primary open-angle glaucoma (POAG), which accounts for over two-thirds of all glaucoma cases, has an estimated UK prevalence in 2017 of approximately 2% of people over...

Vitreomacular traction: natural course vs. vitrectomy vs. ocriplasmin

Over time, the vitreous gel completely separates from the retina in a process known as a posterior vitreous detachment (PVD). In some instances, however, the vitreous does not detach entirely and remains adherent to the macula. The term vitreomacular traction...

Corneal Transplantation

This relatively small book provides a thorough overview of the history of corneal transplantation, an update on the anatomy and physiology of the cornea with particular reference to the components essential to keratoplasty procedures, also graft preparation and storage. There...

Pseudophakic Monovision: A Clinical Guide

The contents of this small volume should provide useful tips for all ophthalmic practitioners involved with managing patients undergoing cataract surgery. For those ophthalmic clinicians and supporting staff not familiar with the potential options for achieving a spectacle independent refractive...

Does intravitreal bevacizumab help in diabetic retinopathy related vitreous haemorrhage?

This retrospective, interventional case series, aimed to assess the effectiveness of intravitreal bevacizumab (IVB) in vitreous haemorrhage secondary to proliferative diabetic retinopathy. The primary outcome was the rate of vitrectomy (PPV) after IVB, with secondary outcomes the number of IVB...

Clinical evaluation of a new pupil independent diffractive MIOL lens with a ±2.75D near addition

This is a clinical outcome assessment after cataract surgery with implantation of multifocal intraocular lens implant IOL with a lower near addition (+2.75D) of 143 eyes of 85 patients aged between 40 to 83 years of age. The type of...

Intravitreal Bevacizumab for the prevention of postoperative proliferative vitreoretinopathy in high-risk patients

This single- centre observational retrospective study was conducted to evaluate the effect of intravitreal injection of bevacizumab at the time surgery for rhegmatogenous retinal detachment (RRD) repair on postoperative proliferative vitreoretinopathy (PVR) in patients at high risk selected by laser...

College comments on the DHSC’s update on GOS sight test fees for England and clinical placement training payments for 2025/2026

This week, the Department of Health and Social Care published details of its confirmed NHS sight test fee and NHS domiciliary fees from 1 April 2025, continuing professional development payments for 2024, and clinical placement training payments from 1 April...

Intravitreal afibercept and ranibizumab for PCV

This is a retrospective, interventional series comprising 98 eyes with polypidal choroidal vasculopathy (PCV) with the aim of comparing treatments with afibercept and ranibizumab, highlighting any differences in their efficacy. Case notes and imaging (FFA / ICG / OCT) were...

Scottish budget 2026–27: Optometry Scotland welcomes continued investment in community eyecare

Optometry Scotland (OS) welcomes the Scottish Budget 2026–27, which confirms continued investment in community optometry and reinforces its established role in delivering accessible eyecare across Scotland. The Budget confirms community eyecare funding of £144.5 million for 2026–27, representing a cash...

Ophtherminator 3 - Rise of the Machines

“Bring back life form, priority one, all other priorities are rescinded.” Film buffs will spot this as a chilling quote spoken by Ash (Ian Holm) from the classic sci-fi horror movie Alien (1979). Ash (spoiler alert) is a Hyperdyne Systems...